Skip to main content
logo
Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
339.64
-5.66 (-1.64%)
Sep 10, 2026, 2:30 PM EDT - Market open

PRAX Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--8.552.45--
Revenue Growth
--249.53%---
Cost of Revenue
290.71267.12152.4186.77154.44-
Gross Profit
-290.71-267.12-143.86-84.32-154.44-
Selling, General & Admin
87.4659.0856.3142.0559.5547.08
Research & Development
-----120.26
Operating Expenses
87.4659.0856.3142.0559.55167.33
Operating Income
-378.17-326.2-200.17-126.37-213.99-167.33
Interest & Investment Income
36.3219.3412.343.141.962.36
EBT Excluding Unusual Items
-341.85-306.86-187.83-123.23-212.03-164.97
Merger & Restructuring Charges
-----1-
Gain (Loss) on Sale of Investments
2.723.595.01-0.05-1-2.09
Pretax Income
-339.13-303.27-182.82-123.28-214.03-167.06
Net Income
-339.13-303.27-182.82-123.28-214.03-167.06
Net Income to Common
-339.13-303.27-182.82-123.28-214.03-167.06
Net Income Growth
------
Shares Outstanding (Basic)
262318733
Shares Outstanding (Diluted)
262318733
Shares Change
29.56%25.68%171.55%114.58%8.58%374.34%
EPS (Basic)
-12.86-13.48-10.21-18.69-69.65-59.03
EPS (Diluted)
-12.86-13.48-10.21-18.69-69.65-59.03
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-305.38-249.12-131.76-111.19-185.49-125.6
Free Cash Flow Per Share
-11.58-11.07-7.36-16.86-60.36-44.38
Operating Margin
---2340.29%-5164.40%--
Profit Margin
---2137.48%-5037.88%--
Free Cash Flow Margin
---1540.48%-4543.77%--
EBITDA
-378.05-326.06-199.81-125.94-213.57-167.15
D&A For EBITDA
0.120.140.360.430.420.18
EBIT
-378.17-326.2-200.17-126.37-213.99-167.33
SEC Filings: 10-K · 10-Q